Exploring 3 Undiscovered Gems in Middle East Markets
SMC HEALTHCARE 4019.SA | 0.00 |
As Gulf equities experience mixed results amid geopolitical uncertainties surrounding the Strait of Hormuz, investor sentiment remains cautiously optimistic with hopes for a potential peace deal. In this climate, identifying promising stocks involves looking for companies that demonstrate resilience and potential growth despite regional tensions.
Top 10 Undiscovered Gems With Strong Fundamentals In The Middle East
| Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
|---|---|---|---|---|
| Analyst I.M.S. Investment Management Services | NA | 33.12% | 45.12% | ★★★★★★ |
| Ilex Medical | NA | -2.62% | -29.83% | ★★★★★★ |
| Payton Industries | NA | 1.92% | 13.55% | ★★★★★★ |
| Terminal X Online | 10.00% | 13.43% | 45.34% | ★★★★★★ |
| Tureks Turizm Tasimacilik Anonim Sirketi | 5.61% | 45.04% | 46.56% | ★★★★★★ |
| Yeni Gimat Gayrimenkul Yatirim Ortakligi | 2.52% | 43.31% | 23.27% | ★★★★★☆ |
| Gür-Sel Turizm Tasimacilik ve Servis Ticaret | 4.54% | 30.75% | 51.95% | ★★★★★☆ |
| Hamat Group | 44.59% | 3.36% | -28.02% | ★★★★☆☆ |
| Mobiltel Iletisim Hizmetleri Sanayi ve Ticaret | 22.16% | 9.01% | -17.85% | ★★★★☆☆ |
| Pasifik Holding | 0.05% | 444.27% | 1482.90% | ★★★★☆☆ |
We'll examine a selection from our screener results.
Çimentas Izmir Çimento Fabrikasi Türk (IBSE:CMENT)
Simply Wall St Value Rating: ★★★★★★
Overview: Çimentas Izmir Çimento Fabrikasi Türk A.S. operates in Turkey, focusing on the production, trading, sale, and transportation of cement with a market capitalization of TRY29.38 billion.
Operations: Çimentas Izmir Çimento Fabrikasi Türk A.S. generates revenue primarily from its cement segment, which contributes TRY13.15 billion, followed by ready-mixed concrete at TRY5.04 billion. The company also has smaller revenue streams from aggregates and waste management, amounting to TRY679 million and TRY259 million respectively.
Çimentas Izmir Çimento Fabrikasi Türk, a nimble player in the Basic Materials sector, has shown resilience despite recent challenges. The company is debt-free now, a significant shift from a 7% debt-to-equity ratio five years back. Its Price-To-Earnings ratio of 24.5x is attractive compared to the industry average of 25.3x, suggesting potential value for investors. However, earnings growth was negative at -2.9%, though still better than the industry's -40.7%. Recent financials reveal sales of TRY 17 billion and net income of TRY 1.2 billion for 2025, indicating stable operations amidst fluctuating market conditions.
Specialized Medical (SASE:4019)
Simply Wall St Value Rating: ★★★★★★
Overview: Specialized Medical Company operates hospitals, clinics, and medical centers in Saudi Arabia with a market capitalization of SAR4.79 billion.
Operations: Specialized Medical generates revenue primarily from its hospitals and healthcare facilities, which contribute SAR1.25 billion, while pharmacies and others add SAR283.73 million.
Specialized Medical stands out with its strong financial performance and promising growth trajectory. Its earnings surged by 43.7% over the past year, significantly outpacing the Healthcare industry's 14.2% growth rate. The company reported a net income of SAR 266 million for 2025, up from SAR 185 million the previous year, supported by a substantial one-off gain of SAR 60 million. With a debt to equity ratio reduced to 44.9% over five years and interest payments well-covered at an EBIT coverage of 5.5x, it appears financially robust. Additionally, its price-to-earnings ratio of 18x is below industry average, suggesting potential value for investors seeking opportunities in this sector.
Danel (Adir Yeoshua) (TASE:DANE)
Simply Wall St Value Rating: ★★★★★☆
Overview: Danel (Adir Yeoshua) Ltd is an Israeli company specializing in human resources services, with a market capitalization of ₪2.83 billion.
Operations: Danel generates revenue primarily from five segments: Productivity (₪14.80 million), Medical Services (₪262.56 million), Manpower in Human Resources (₪458.85 million), Facilities for People with Special Needs (₪616.23 million), and Auxiliary Force in Nursing (₪1.55 billion).
Danel (Adir Yeoshua) has shown a notable performance with its earnings growing by 258% over the past year, significantly outpacing the Professional Services industry average of 9.7%. The company reported net income of ILS 116.95 million for the year ending December 2025, a substantial increase from ILS 20.51 million in the previous year. Its debt to equity ratio rose from 9.3% to 14.4% over five years, yet it holds more cash than total debt, ensuring financial stability. Trading at an estimated value below fair market price and boasting high-quality earnings, Danel presents intriguing potential for investors seeking growth opportunities in emerging markets like the Middle East.
Make It Happen
- Investigate our full lineup of 221 Middle Eastern Undiscovered Gems With Strong Fundamentals right here.
- Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
- Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
Curious About Other Options?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
